Naftali Stern

3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial

Carel W. le Roux, Arne Astrup, Ken Fujioka et al. · The Lancet · 2017 · 813 citations

Obesity, Metabolic Syndrome, Nutrition +8

Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial

Stefano Del Prato, Steven E. Kahn, Imre Pávó et al. · The Lancet · 2021 · 586 citations

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

25-Hydroxyvitamin D ₃ -1α-Hydroxylase Is Expressed in Human Vascular Smooth Muscle Cells and Is Upregulated by Parathyroid Hormone and Estrogenic Compounds

Dalia Sömjen, Yosef Weisman, Förtüne Kohen et al. · Circulation · 2005 · 364 citations

The Fatty Acid–Bile Acid Conjugate Aramchol Reduces Liver Fat Content in Patients With Nonalcoholic Fatty Liver Disease

Rifaat Safadi, Fred M. Konikoff, Mahmud Mahamid et al. · Clinical Gastroenterology and Hepatology · 2014 · 270 citations · Full text

Ghrelin secretion is modulated in a nutrient‐ and gender‐specific manner

Yona Greenman, Nehama Golani, S. Gilad et al. · Clinical Endocrinology · 2004 · 236 citations